logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

HYPEBEAST purchased 3,371,200 shares at a cost of HK$582,900 on March 19th.

date
19:55 19/03/2026
avatar
GMT Eight
HYPEBEAST (00150) announced that on March 19, 2026, it spent 582,900 Hong Kong dollars to repurchase 3,371,200 shares.
HYPEBEAST (00150) announced on March 19, 2026 that it has spent HK$582,900 to repurchase 3,371,200 shares.
Related Articles
HK Stock
CHINA HONGBAO(08316): Liu Huiqing appointed as independent non-executive director.
HK Stock
CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.
HK Stock
Hong Kong-listed AI medical stock buys back the first share! YIDU TECH (02158) repurchased nearly 15 million Hong Kong dollars on March 19, deepening regional layout with Guangxi Medical University.
CHINA HONGBAO(08316): Liu Huiqing appointed as independent non-executive director.
HK Stock
CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.
HK Stock
Hong Kong-listed AI medical stock buys back the first share! YIDU TECH (02158) repurchased nearly 15 million Hong Kong dollars on March 19, deepening regional layout with Guangxi Medical University.
HK Stock
RECOMMEND
“Memory Price Surge” For 100 Days, Low‑End Smartphones Forced Into Decline
“Memory Price Surge” For 100 Days, Low‑End Smartphones Forced Into Decline
icon
19/03/2026
Hong Kong Suddenly Becomes A New Destination For Middle Eastern Capital? Signs Of Increased Allocation Are Evident
Hong Kong Suddenly Becomes A New Destination For Middle Eastern Capital? Signs Of Increased Allocation Are Evident
icon
19/03/2026
Memory Price Surge Persists For 100 Days, Forcing Low‑End Smartphones Toward Extinction
Memory Price Surge Persists For 100 Days, Forcing Low‑End Smartphones Toward Extinction
icon
19/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.